Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 36.47m |
Free float | 36.25m |
P/E (TTM) | -- |
Market cap | 19.72m USD |
EPS (TTM) | -5.57 USD |
--
More ▼
Announcements
- Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
- Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
- Biora Therapeutics Achieves ISO 13485 Certification
- Biora Therapeutics Announces Positive Nasdaq Listing Decision
- Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- Biora Therapeutics Announces Funding Agreement with Existing Investors
- Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
- Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
- Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
More ▼